Soleil Securities initiates coverage on Ardea Biosciences (Nasdaq: RDEA) with a Buy. Price target $27.

Soleil analyst says, "We are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE